Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Chordoma is a malignant tumor of the bone and should be always considered when a midline tumor of the axial skeleton is found. The majority of chordomas affect the sacral region, representing 49% of all the cases. There is a modest male prevalence and a peak incidence between the fifth and seventh decades of life. Chordomas follow a slow progressive course, with aggressive local invasion and metastasis. Patients usually present with an advanced disease, and the symptoms usually result from neurological compression or invasion to adjacent organs. Perineal pain and neurological deficits are often reported. Other symptoms include constipation, urinary incontinence, and rectal bleeding. The best strategy to reduce recurrence and improve long-term prognosis is total resection with wide margins spanning surrounding healthy tissue. However, the close proximity to neural and pelvic structures decreases the feasibility for obtaining negative margins without serious morbidity, such as sexual dysfunction and bowel incontinence. High-dose radiotherapy (60–70 Gy) can be used as either adjuvant therapy or main treatment when operative management is not possible. Despite this, chordomas exhibit significant resistance to radiotherapy and chemotherapy, and recurrence occurs in virtually all cases. Complete surgical resection for local sacral recurrences is recommended in the literature. In this chapter, we discuss the case of a middle aged man with a history of bilateral posterior thigh pain whose symptoms originated from a large anterior sacral space occupying lesion.
Chief complaint: leg pain and urinary incontinence
History of present illness: This is a 57-year-old male patient with a history of hypertension and coronary artery disease who presented with bilateral posterior thigh pain for 3 to 4 months and new urinary incontinence. The patient underwent a magnetic resonance image of the lumbosacral spine that showed a large mass occupying the upper sacral segment with soft tissue involvement. ( Fig. 60.1 ).
Medications: amlodipine, aspirin
Allergies: no known drug allergies
Past medical and surgical history: hypertension, coronary artery disease
Family history: noncontributory
Social history: no smoking or alcohol
Physical examination: awake, alert, and oriented to person, place, and time; cranial nerves II–XII intact; bilateral deltoids/triceps/biceps 5/5; interossei 5/5; iliopsoas/knee flexion/knee extension/dorsi, and plantar flexion 5/5
Reflexes: 2+ in bilateral biceps/triceps/brachioradialis with negative Hoffman; 2+ in bilateral patella/ankle; no clonus or Babinski; sensation diminished in perianal area
|
|
|
|
|
---|---|---|---|---|
Preoperative | ||||
Additional tests requested | CT-guided biopsy confirming chordoma | CT sacrum and pelvis |
|
|
Surgical approach selected |
|
|
|
Transabdominal L5 and sacral transverse osteotomy and sacrectomy with L3-iliac fusion |
Goal of surgery | En bloc resection with negative margins | En bloc resection, reconstruction/stabilization of spine | En bloc resection with negative margins | En bloc resection with negative margins, fixation |
Perioperative | ||||
Positioning |
|
|
|
|
Surgical equipment | Stage 1: vascular and abdominal surgeon |
|
|
|
Medications | None | None | Tranexamic acid | None |
Anatomical considerations | Dural sac, aorta and inferior vena cava bifurcation, hypogastric arteries and veins, piriformis, rectum | Stage 1: great vessels, peritoneal contents, iliac vessels, lumbosacral plexusStage 2: thecal sac, bilateral L5 nerve roots | Iliac vessels, middle sacral vessels, superior gluteal vessels, rectum, descending colon, ureters, L5 nerve roots | Sacrum, pelvis, pars lateralis, ventral ligamentous complex, aorta, iliac arteries, sacral middle artery, lateral sacral arteries, sacral plexus |
Complications feared with approach chosen | CSF leak, arterial or venous bleeding, tumor breach, rectal perforation | Tumor breach, injury to vascular structures, unintended injury to nerves, CSF leak | Catastrophic bleeding, colonic perforation, ureteral injury | Vascular injury, nerve root injury |
Intraoperative | ||||
Anesthesia | General | General | General | General |
Exposure |
|
Stage 1: L5-S1 Stage 2: L2-sacrum |
|
L5-sacrum |
Levels decompressed |
|
|
|
L5-S1 |
Levels fused |
|
|
|
L3-iliac |
Surgical narrative | Stage 1: vascular surgeon and abdominal surgeon, midline laparotomy, vascular surgery to free great vessels/iliac vessels, ligate both hypogastric arteries and veins, anterior L5 osteotomy and start bilateral iliac osteotomiesStage 2 (same day): prone position, Mercedes-like incision, subperiosteal dissection, L4–5 laminectomy, ligate thecal sac at L4–5 level and transect above L5 nerve roots, full tumor release making sure to leave healthy tissue all around, cut piriformis muscle bilaterally as far as possible, cut the ligament from the coccyx and the sacrospinous and sacrotuberous ligaments, complete osteotomies of L5 and iliac wings, en bloc removal, Varga-type | Stage 1: position supine, IOM baseline, midline laparotomy, vascular surgery to free great vessels/iliac vessels and expose lower lumbar spine and anterior sacral pelvis, plastics to harvest VRAM, colorectal surgery performs colectomy, attach surgical navigation and perform intraoperative CT, dissect bilateral L5 nerve roots to lumbosacral plexus, dissect medial to psoas muscles bilaterally and free up L4 and L5 contribution to plexus, L5-S1 anterior annulotomy and discectomy making sure to disconnect lateral annula, score medial pelvis just lateral to SI joints, place silastic sheath to protect vessels and nerves from tumor, VRAM placed into pelvis and incision closedStage 2 (2 days | Preoperative placement of ureteral stents, bowel prep, IVC filterStage 1: position supine, anterior midline laparotomy by vascular surgery down to presacral space and lumbosacral junction, mobilize aortic and IVC bifurcation / middle sacral vessels/bilateral internal iliac vessels/external iliac vessel down to pelvis, identify L5 nerve roots and dissect off of tumor, dissect mesorectum and descending colon off of tumor with colorectal surgery with possible diverting colostomy if tumor adherent/infiltrative or cannot obtain adequate exposure, transverse cut into L5 vertebral body above tumor through ALL and down to PLL, place silastic sheath between tumor and external iliac | Stage 1: GI or general surgeon to perform transabdominal incision via an infraumbilical incision, mobilize aorta and IVC as well as middle and lateral sacral vessels, expose L5 and sacrum, osteotomy guided by surgical navigation through L5 and sacrum, complete radical resection, placement of pedicle screws and L3–5 with iliac screws, place rods for L3-iliac fusion |
|
later): position prone, baseline IOM, expose L2- sacrum, intraoperative navigation and CT scan that is fused to preoperative MRI, place bilateral L2-4 pedicle screws and pelvis screws, cannulate and tap L5 pedicle screws, L5 laminectomy and facetectomy, complete posterior L5-S1 discectomy, thecal sac tied off at L5-S1 with silk ties and divided, drill the pelvis just lateral to the SI joint using navigation, complete bony disconnection with osteotome, dissect sacrum down to the most inferior aspect and disconnect muscle attachments, rotate specimen to deliver it, protect L4 and L5 contribution to the plexus, remove specimen en bloc, inspect the specimen to ensure there is no breach, remove silastic sheath, place L5 pedicle screws, femur shaft sized in placed with ilium-femur-ilium screw at normal sacral promontory position, fibula grafts are sized and placed in effect and anchored between inferior aspect of L5 vertebral body and medial remaining pelvis and secure in place with screws in a V-shape, four-rod construct is placed with each of the rods secured using pelvic screws and multiple side-to-side connectors, place horizontal cross rod between left and right pelvic screws, VRAM is pulled out to fill defect, decorticate and place allograft on all bony surfaces, plastics surgery to close in anatomical layers with drains |
|
||
double iliac screws, fashion structural femoral allograft to wedge against lateral osteotomies for pelvic ring reconstruction, horizontal rods across iliac screws with double vertical rods up to L3 with cross connectors for four-rod reconstruction, cable femoral structural allograft to horizontal rods across ilium, examine for CSF leak, decorticate exposed bone surfaces and place morselized allograft, identify VRAM from stage 1 and obliterate sacral dead space to prevent bowel herniation, plastic surgery closure | ||||
Complication avoidance | Multidisciplinary team approach, free anterior border to tumor before posterior, ligate thecal sac above L5 nerve roots, en bloc resection, Varga-type reconstruction, femoral shaft allograft with titanium cage to reconstruct defect | Multidisciplinary team approach, silastic sheath to protect nerves and vessels, VRAM to fill dead space, surgical navigation tow staged approach, en bloc resection, four-rod construct, plastics surgery closure | Preoperative placement of ureteral stents/bowel prep/IVC filter, staged procedure, multidisciplinary care, preserve L5 nerve roots, silastic sheath to protect vessels for posterior portion of surgery, VRAM flap to close dead space, surgical navigation, flood field with water to lyse microtumor cells, | Preoperative angiogram and possible embolization, general surgery to perform the approach, surgical navigation |
Postoperative | ||||
Admission | ICU | ICU | ICU | ICU |
Postoperative complications feared | CSF leak, wound dehiscence, hematoma, wound infection | CSF leak, wound dehiscence, wound infection, hardware failure | CSF leak, wound dehiscence, L5 nerve root injury, medical complications, lower extremity vascular insufficiency | Vascular injury, nerve root injury |
Anticipated length of stay | 12–14 days | 7 days | 5–7 days | 4–5 days |
Follow-up testing | MRI every 6 months for 5 years |
|
|
|
Bracing | None | None | None | None |
Follow-up visits | 2 weeks and 6 months after surgery | 2 weeks and 3 months after surgery | 2 weeks after surgery | 7 days and 2 weeks after surgery |
Radiation therapy for STR | Carbon ion | Proton beam | Proton beam or stereotactic radiosurgery | External beam radiation |
Radiation therapy for GTR | Observation | Observation | Proton beam or stereotactic radiosurgery | Observation |
Chordoma
Chondrosarcoma
Giant cell tumor
Plasmacytoma
Glioma
Metastatic tumor
Ewing sarcoma
Chronic infections (tuberculosis, fungus)
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here